As such, we are involved in the Marseille immunology biotope
I am the Director of Protisvalor, the research transfer subsidiary of Aix-Marseille University. Protisvalor was founded in 2002 to provide laboratories and researchers with the necessary assistance to valorize their expertise and the results of their research. Since then, we have actively supported the University’s teams in their innovation activities and collaborations with industry and ensure the administrative and financial management of strategic R&D platforms, such as the MI-mAbs pre-industrial demonstrator.
As such, we are involved in the Marseille immunology biotope, so it is natural that today we fully support this initiative.#ecosystem
MI is a diamond of the new Metropolis, offering a unique opportunity to drive science forward and provide more effective therapeutic options for our cancer patients.
New molecules currently under development at Innate Pharma and in new companies in Marseille reflect the teams' dynamism and local potential.
Our aim is simple: to position ourselves upstream of the diagnosis and to propose innovative treatments to patients
AMU, IPC, CRCM
By creating this super innovation centre "outside the walls", which is Marseille Immunopole, we leverage our capabilities to ensure better and faster innovation.